Drugs that contain Albuterol Sulfate
1. Accuneb patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6702997 | MYLAN SPECIALITY LP | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
Dec, 2021
(2 years ago) | |
Market Authorisation Date: 30 April, 2001
Treatment: Indicated for the relief of bronchospasm in patients 2-12 years of age with asthma (reversible obstructive airway disease)
Dosage: SOLUTION;INHALATION
ACCUNEB family patents
2. Proair Digihaler patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6718972 | TEVA BRANDED PHARM | Dose metering system for medicament inhaler |
Jun, 2021
(2 years ago) | |
| US6871646 | TEVA BRANDED PHARM | De-agglomerator for breath-actuated dry powder inhaler |
Jun, 2021
(2 years ago) | |
| US8006690 | TEVA BRANDED PHARM | Reservoir pressure system for medicament inhaler |
Jun, 2021
(2 years ago) | |
| US6701917 | TEVA BRANDED PHARM | Dose counter for medicament inhaler |
Jun, 2021
(2 years ago) | |
| US6748947 | TEVA BRANDED PHARM | De-agglomerator for breath-actuated dry powder inhaler |
Jun, 2021
(2 years ago) | |
| US7540282 | TEVA BRANDED PHARM | Reservoir pressure system for medicament inhaler |
May, 2023
(11 months ago) | |
| US10765820 | TEVA BRANDED PHARM | Dry powder inhalation apparatus |
May, 2025
(1 year, 22 days from now) | |
| US9463288 | TEVA BRANDED PHARM | Dry powder inhalation apparatus |
May, 2025
(1 year, 22 days from now) | |
| US8651103 | TEVA BRANDED PHARM | Dry powder inhalation apparatus |
Mar, 2028
(3 years from now) | |
| US10124131 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US9731087 | TEVA BRANDED PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
| US10022510 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US9216260 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jun, 2031
(7 years from now) | |
| US10561808 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(7 years from now) | |
| US8978966 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jan, 2032
(7 years from now) | |
| US9782551 | TEVA BRANDED PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(11 years from now) | |
| US9782550 | TEVA BRANDED PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(11 years from now) | |
| US10918816 | TEVA BRANDED PHARM | Compliance monitoring module for a breath-actuated inhaler |
Dec, 2035
(11 years from now) | |
| US10569034 | TEVA BRANDED PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2036
(12 years from now) | |
| US11351317 | TEVA BRANDED PHARM | Drug delivery device with electronics |
Feb, 2038
(13 years from now) | |
| US11357935 | TEVA BRANDED PHARM | Drug delivery device with electronics |
Sep, 2038
(14 years from now) | |
| US11000653 | TEVA BRANDED PHARM | Inhaler |
Dec, 2038
(14 years from now) | |
| US11344685 | TEVA BRANDED PHARM | Drug delivery device with electronics |
Sep, 2039
(15 years from now) | |
| US11439777 | TEVA BRANDED PHARM | Drug delivery device with electronics |
May, 2040
(16 years from now) | |
| US11464923 | TEVA BRANDED PHARM | Inhaler system |
Jun, 2040
(16 years from now) | |
| US11173259 | TEVA BRANDED PHARM | Drug delivery device with electronics and power management |
Jul, 2040
(16 years from now) | |
| US11266796 | TEVA BRANDED PHARM | Inhalation device with integrated electronics |
Feb, 2041
(16 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Mar 12, 2018 |
| New Patient Population(NPP) | Apr 28, 2019 |
Market Authorisation Date: 21 December, 2018
Treatment: NA
Dosage: POWDER, METERED;INHALATION
PROAIR DIGIHALER family patents
3. Proair Hfa patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5605674 | TEVA BRANDED PHARM | Medicinal aerosol formulations |
Feb, 2014
(10 years ago) | |
| US7566445 | TEVA BRANDED PHARM | Medicinal aerosols and methods of delivery thereof |
Jun, 2017
(6 years ago) | |
| US8834849 | TEVA BRANDED PHARM | Medicinal aerosols and methods of delivery thereof |
Jun, 2017
(6 years ago) | |
| US6446627 | TEVA BRANDED PHARM | Inhaler dose counter |
Dec, 2017
(6 years ago) | |
| US7105152 | TEVA BRANDED PHARM | Suspension aerosol formulations |
Sep, 2023
(7 months ago) | |
| US8132712 | TEVA BRANDED PHARM | Metered-dose inhaler |
Sep, 2028
(4 years from now) | |
| US10086156 | TEVA BRANDED PHARM | Dose counter for inhaler and method for counting doses |
May, 2031
(7 years from now) | |
| US9463289 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US10022510 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US10695512 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US9808587 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US10022509 | TEVA BRANDED PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
| US11395889 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US10561808 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(7 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Patient Population(NPP) | Sep 16, 2011 |
Market Authorisation Date: 29 October, 2004
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
PROAIR HFA family patents
4. Proair Respiclick patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6446627 | TEVA BRANDED PHARM | Inhaler dose counter |
Dec, 2017
(6 years ago) | |
| US6748947 | TEVA BRANDED PHARM | De-agglomerator for breath-actuated dry powder inhaler |
Jun, 2021
(2 years ago) | |
| US6701917 | TEVA BRANDED PHARM | Dose counter for medicament inhaler |
Jun, 2021
(2 years ago) | |
| US6871646 | TEVA BRANDED PHARM | De-agglomerator for breath-actuated dry powder inhaler |
Jun, 2021
(2 years ago) | |
| US8006690 | TEVA BRANDED PHARM | Reservoir pressure system for medicament inhaler |
Jun, 2021
(2 years ago) | |
| US6718972 | TEVA BRANDED PHARM | Dose metering system for medicament inhaler |
Jun, 2021
(2 years ago) | |
| US7540282 | TEVA BRANDED PHARM | Reservoir pressure system for medicament inhaler |
May, 2023
(11 months ago) | |
| US9463288 | TEVA BRANDED PHARM | Dry powder inhalation apparatus |
May, 2025
(1 year, 22 days from now) | |
| US10765820 | TEVA BRANDED PHARM | Dry powder inhalation apparatus |
May, 2025
(1 year, 22 days from now) | |
| US8651103 | TEVA BRANDED PHARM | Dry powder inhalation apparatus |
Mar, 2028
(3 years from now) | |
| US10022510 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US10124131 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US9731087 | TEVA BRANDED PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
| US9216260 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jun, 2031
(7 years from now) | |
| US10561808 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(7 years from now) | |
| US8978966 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jan, 2032
(7 years from now) | |
| US9782551 | TEVA BRANDED PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(11 years from now) | |
| US9782550 | TEVA BRANDED PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(11 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Mar 12, 2018 |
| New Patient Population(NPP) | Apr 28, 2019 |
Market Authorisation Date: 21 December, 2018
Treatment: NA
Dosage: POWDER, METERED;INHALATION
PROAIR RESPICLICK family patents
5. Proventil-hfa patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5605674 | KINDEVA | Medicinal aerosol formulations |
Feb, 2014
(10 years ago) | |
| US5775321 | KINDEVA | Seal configuration for aerosol canister |
Jul, 2015
(8 years ago) | |
| US6006745 | KINDEVA | Device for delivering an aerosol |
Dec, 2016
(7 years ago) | |
Market Authorisation Date: 15 August, 1996
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
PROVENTIL-HFA family patents
6. Ventolin Hfa patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6596260 | GLAXOSMITHKLINE | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Aug, 2014
(9 years ago) | |
|
US6596260 (Pediatric) | GLAXOSMITHKLINE | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Feb, 2015
(9 years ago) | |
| US6558651 | GLAXOSMITHKLINE | Aerosols containing annealed particulate salbutamol and tetrafluoroethane |
Dec, 2016
(7 years ago) | |
|
US6558651 (Pediatric) | GLAXOSMITHKLINE | Aerosols containing annealed particulate salbutamol and tetrafluoroethane |
Jun, 2017
(6 years ago) | |
| US6510969 | GLAXOSMITHKLINE | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6315173 | GLAXOSMITHKLINE | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6170717 | GLAXOSMITHKLINE | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6966467 | GLAXOSMITHKLINE | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6997349 | GLAXOSMITHKLINE | Indicating device |
Jan, 2018
(6 years ago) | |
| US6161724 | GLAXOSMITHKLINE | Indicating device |
Jan, 2018
(6 years ago) | |
| US7143908 | GLAXOSMITHKLINE | Indicating device |
Jan, 2018
(6 years ago) | |
| US6938796 | GLAXOSMITHKLINE | Indicating device |
Jan, 2018
(6 years ago) | |
| US6435372 | GLAXOSMITHKLINE | Delivery system for a medicament and method for the assembly thereof |
Jan, 2018
(6 years ago) | |
| US7107986 | GLAXOSMITHKLINE | Dispenser with doses' counter |
Jun, 2018
(5 years ago) | |
| US6431168 | GLAXOSMITHKLINE | Dispenser with doses′ counter |
Jun, 2018
(5 years ago) | |
|
US6170717 (Pediatric) | GLAXOSMITHKLINE | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6315173 (Pediatric) | GLAXOSMITHKLINE | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6510969 (Pediatric) | GLAXOSMITHKLINE | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6966467 (Pediatric) | GLAXOSMITHKLINE | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6161724 (Pediatric) | GLAXOSMITHKLINE | Indicating device |
Jul, 2018
(5 years ago) | |
|
US6997349 (Pediatric) | GLAXOSMITHKLINE | Indicating device |
Jul, 2018
(5 years ago) | |
|
US6938796 (Pediatric) | GLAXOSMITHKLINE | Indicating device |
Jul, 2018
(5 years ago) | |
|
US6435372 (Pediatric) | GLAXOSMITHKLINE | Delivery system for a medicament and method for the assembly thereof |
Jul, 2018
(5 years ago) | |
|
US7143908 (Pediatric) | GLAXOSMITHKLINE | Indicating device |
Jul, 2018
(5 years ago) | |
| US7350676 | GLAXOSMITHKLINE | Valve for aerosol container |
Aug, 2018
(5 years ago) | |
|
US7107986 (Pediatric) | GLAXOSMITHKLINE | Dispenser with doses' counter |
Dec, 2018
(5 years ago) | |
|
US6431168 (Pediatric) | GLAXOSMITHKLINE | Dispenser with doses′ counter |
Dec, 2018
(5 years ago) | |
|
US7350676 (Pediatric) | GLAXOSMITHKLINE | Valve for aerosol container |
Feb, 2019
(5 years ago) | |
| US9861771 | GLAXOSMITHKLINE | Device housing for an aerosol container |
Oct, 2020
(3 years ago) | |
| US6743413 | GLAXOSMITHKLINE | Suspension aerosol formulations |
Jun, 2021
(2 years ago) | |
|
US6743413 (Pediatric) | GLAXOSMITHKLINE | Suspension aerosol formulations |
Dec, 2021
(2 years ago) | |
| US7832351 | GLAXOSMITHKLINE | Actuation indicator for a dispensing device |
Jun, 2023
(10 months ago) | |
|
US7832351 (Pediatric) | GLAXOSMITHKLINE | Actuation indicator for a dispensing device |
Dec, 2023
(4 months ago) | |
| US7500444 | GLAXOSMITHKLINE | Actuation indicator for a dispensing device |
Feb, 2026
(1 year, 10 months from now) | |
|
US7500444 (Pediatric) | GLAXOSMITHKLINE | Actuation indicator for a dispensing device |
Aug, 2026
(2 years from now) | |
Market Authorisation Date: 19 April, 2001
Treatment: The treatment or prevention of bronchospasm in adults and children 4 years of age and older with reversible obstructive airways disease and the prevention of exercised-induced bronchospasm in patients...
Dosage: AEROSOL, METERED;INHALATION
VENTOLIN HFA family patents